Marta Sabara

1.4k total citations
45 papers, 1.1k citations indexed

About

Marta Sabara is a scholar working on Infectious Diseases, Genetics and Epidemiology. According to data from OpenAlex, Marta Sabara has authored 45 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Infectious Diseases, 18 papers in Genetics and 16 papers in Epidemiology. Recurrent topics in Marta Sabara's work include Viral gastroenteritis research and epidemiology (33 papers), Virus-based gene therapy research (16 papers) and Animal Virus Infections Studies (12 papers). Marta Sabara is often cited by papers focused on Viral gastroenteritis research and epidemiology (33 papers), Virus-based gene therapy research (16 papers) and Animal Virus Infections Studies (12 papers). Marta Sabara collaborates with scholars based in Canada, United States and United Arab Emirates. Marta Sabara's co-authors include Lorne A. Babiuk, P.J. Frenchick, Dirk Deregt, J. E. Gilchrist, Hana M. Weingartl, John Pasick, L. A. Babiuk, Oswald Jarrett, Lizhong Luo and Vikram Misra and has published in prestigious journals such as The Journal of Immunology, Journal of Virology and Virology.

In The Last Decade

Marta Sabara

44 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marta Sabara Canada 18 779 397 363 226 226 45 1.1k
M. M. Willcocks United Kingdom 24 1000 1.3× 558 1.4× 485 1.3× 442 2.0× 358 1.6× 39 1.6k
Selene Zárate Mexico 18 837 1.1× 326 0.8× 361 1.0× 224 1.0× 215 1.0× 32 1.3k
W. L. Curran United Kingdom 17 536 0.7× 677 1.7× 386 1.1× 181 0.8× 158 0.7× 35 1.0k
Pavel Iša Mexico 20 936 1.2× 416 1.0× 338 0.9× 304 1.3× 318 1.4× 42 1.4k
Nobuyuki Minamoto Japan 25 744 1.0× 233 0.6× 249 0.7× 181 0.8× 554 2.5× 64 1.5k
Volker Ohlinger Germany 14 551 0.7× 549 1.4× 252 0.7× 173 0.8× 242 1.1× 26 879
C.R. Wilks Australia 22 414 0.5× 291 0.7× 278 0.8× 87 0.4× 649 2.9× 82 1.4k
Kyoung-Ki Lee South Korea 23 558 0.7× 452 1.1× 371 1.0× 139 0.6× 302 1.3× 66 1.1k
M. Shimizu Japan 20 821 1.1× 656 1.7× 377 1.0× 213 0.9× 131 0.6× 58 1.2k
F. Schmoll Austria 23 507 0.7× 399 1.0× 370 1.0× 88 0.4× 168 0.7× 93 1.3k

Countries citing papers authored by Marta Sabara

Since Specialization
Citations

This map shows the geographic impact of Marta Sabara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marta Sabara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marta Sabara more than expected).

Fields of papers citing papers by Marta Sabara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marta Sabara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marta Sabara. The network helps show where Marta Sabara may publish in the future.

Co-authorship network of co-authors of Marta Sabara

This figure shows the co-authorship network connecting the top 25 collaborators of Marta Sabara. A scholar is included among the top collaborators of Marta Sabara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marta Sabara. Marta Sabara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moniwa, Mariko, Lizhong Luo, Kevin Hills, et al.. (2012). Strain-Specific Monoclonal Antibodies to the E2 Protein of Classical Swine Fever Virus, Paderborn Strain. Hybridoma. 31(5). 340–346. 2 indexed citations
2.
Luo, Lizhong, et al.. (2010). Analysis of expression and glycosylation of avian metapneumovirus attachment glycoprotein from recombinant baculoviruses. Virus Research. 153(2). 244–249. 2 indexed citations
3.
Luo, Lizhong, et al.. (2009). Characterization of the biosynthesis and cell surface expression of avian metapneumovirus attachment glycoprotein. Virus Research. 147(2). 189–194. 1 indexed citations
4.
Luo, Lizhong, et al.. (2009). Analysis of Antigenic Cross-Reactivity Between Subgroup C Avian Pneumovirus and Human Metapneumovirus by Using Recombinant Fusion Proteins. Transboundary and Emerging Diseases. 56(8). 303–310. 8 indexed citations
5.
Luo, Lizhong & Marta Sabara. (2008). Production, Characterization and Assay Application of a Purified, Baculovirus-Expressed, Serogroup Specific Bluetongue Virus Antigen. Transboundary and Emerging Diseases. 55(3-4). 175–182. 5 indexed citations
6.
Berry, Jody D., Steven J.M. Jones, Michael Drebot, et al.. (2004). Development and characterisation of neutralising monoclonal antibody to the SARS-coronavirus. Journal of Virological Methods. 120(1). 87–96. 79 indexed citations
7.
Weingartl, Hana M., et al.. (2002). Continuous porcine cell lines developed from alveolar macrophages. Journal of Virological Methods. 104(2). 203–216. 127 indexed citations
8.
TerWee, Julie A., et al.. (1998). Characterization of the systemic disease and ocular signs induced by experimental infection with Chlamydia psittaci in cats. Veterinary Microbiology. 59(4). 259–281. 35 indexed citations
9.
Jarrett, Oswald, et al.. (1997). Serological analysis of feline calicivirus isolates from the United States and United Kingdom. Veterinary Microbiology. 56(1-2). 55–63. 59 indexed citations
10.
TerWee, Julie A., et al.. (1997). Comparison of the primary signs induced by experimental exposure to either a pneumotrophic or a ‘limping’ strain of feline calicivirus. Veterinary Microbiology. 56(1-2). 33–45. 21 indexed citations
11.
TerWee, Julie A., et al.. (1996). Evaluation of Chlamydia psittaci subfraction and subunit preparations for their protective capacities. Veterinary Microbiology. 48(3-4). 269–282. 13 indexed citations
12.
Ijaz, M. Khalid, Marta Sabara, P.J. Frenchick, et al.. (1995). Characterization of a synthetic peptide mimicking trypsin-cleavage site of rotavirus VP4. Comparative Immunology Microbiology and Infectious Diseases. 18(3). 145–160. 2 indexed citations
13.
Ijaz, M. Khalid, et al.. (1994). Molecular determinants of rotavirus virulence: Localization of a potential virulence site in a murine rotavirus VP4. Comparative Immunology Microbiology and Infectious Diseases. 17(2). 99–110. 3 indexed citations
14.
Ijaz, M. Khalid, et al.. (1993). Characterization of Two Rotaviruses Differing in Their In vitro and In vivo Virulence.. Journal of Veterinary Medical Science. 55(6). 963–971. 3 indexed citations
15.
Redmond, Mark J., et al.. (1993). Assembly of recombinant rotavirus proteins into virus-like particles and assessment of vaccine potential. Vaccine. 11(2). 273–281. 42 indexed citations
16.
Redmond, Mark J., H. Bielefeldt Ohmann, H. P. A. Hughes, et al.. (1991). Rotavirus particles function as immunological carriers for the delivery of peptides from infectious agents and endogenous proteins. Molecular Immunology. 28(3). 269–278. 32 indexed citations
17.
Brey, Robert N., et al.. (1991). Oral Delivery of Antigens in Live Bacterial Vectors. Advances in experimental medicine and biology. 303. 169–184. 14 indexed citations
18.
Deregt, Dirk, Marta Sabara, & Lorne A. Babiuk. (1987). Structural Proteins of Bovine Coronavirus and Their Intracellular Processing. Journal of General Virology. 68(11). 2863–2877. 68 indexed citations
19.
Deregt, Dirk, Marta Sabara, & Lorne A. Babiuk. (1987). Monoclonal Antibodies to Two Bovine Coronavirus Glycoproteins Neutralize Virus Infectivity. Advances in experimental medicine and biology. 218. 473–474. 1 indexed citations
20.
Ijaz, M. Khalid, Marta Sabara, P.J. Frenchick, & Lorne A. Babiuk. (1987). Effect of different routes of immunization with bovine rotavirus on lactogenic antibody response in mice. Antiviral Research. 8(5-6). 283–297. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026